Should children be vaccinated against COVID-19?

Should children be vaccinated against COVID-19?

The BMJ Journals published the article ‘Should children be vaccinated against COVID-19?’ which addresses the ongoing debate on the vaccination of children under 12 years of age against COVID-19. The relatively low risk posed by acute COVID-19 in children, and...

TEDDY Network among the CoE experts in the CP4EUROPE Project

TEDDY Network among the CoE experts in the CP4EUROPE Project

The CP4EUROPE (Strengthening National Child Participation Frameworks and Action in Europe) is a project funded by the European Commission under the DG JUST – Rights, Equality and Citizenship (REC) Programme. It was kicked-off on 1 April 2021 and will last 24 months...

TEDDY Network on CCNE Opinion 136

TEDDY Network on CCNE Opinion 136

TEDDY Network has been mentioned in the Opinion 136 "L’évolution des enjeux éthiques relatifs au consentement dans le soin" of the French Consultative Ethics Committee (Comité Consultatif National d’Ethique - CCNE) related to the ethical issues of the consent...

ENCePP Guide on Methodological Standards in Pharmacoepidemiology

ENCePP Guide on Methodological Standards in Pharmacoepidemiology

The 9th revision of the ENCePP Guide on Methodological Standards in Pharmacoepidemiology has been published on 1 July 2021. The guide offers a single web resource for methodological English language guidance in pharmacoepidemiology and for each topic covered, direct...

Small CAR T Cell Subset for the treatment of Childhood Leukemia

Small CAR T Cell Subset for the treatment of Childhood Leukemia

Scientists and clinicians at UCL and Great Ormond Street Hospital Children's Charity have discovered a small subset of T-cells that may play a key role in chimeric antigen receptor (CAR) T cell therapies against leukaemia in children. The researchers, who assessed and...

Medicines for children & rare diseases – updated rules

Medicines for children & rare diseases – updated rules

With this public consultation, citizens and stakeholders are invited to share their views and experiences on the main obstacles they are facing concerning treatments for rare diseases and children, on possible ways to overcome these obstacles and on how to make the...

Archive